ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule

May 9, 1986

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998